中房股份(600890.SH):聯交所確認中國忠旺可繼續進行分拆忠旺集團的事宜
格隆匯 8 月 14日丨中房股份(600890.SH)公佈,2020年8月14日,公司收到遼寧忠旺精製投資有限公司《關於取得香港聯合交易所有限公司就分拆建議及保證配額豁免書面確認的通知函》。中國忠旺(01333.HK)已經根據香港聯合交易所有限公司證券上市規則第15項應用指引向聯交所提交分拆建議,並於2020年8月14日收到聯交所的書面文件,確認中國忠旺可繼續進行分拆遼寧忠旺集團有限公司(“忠旺集團”)的事宜,並豁免中國忠旺遵守聯交所證券上市規則第15項應用指引下有關保證配額的適用規定。中國忠旺分拆忠旺集團的事宜尚需經中國忠旺股東大會批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.